Results 181 to 190 of about 2,011,052 (344)
ABSTRACT The ascent of novel alternative methods in drug development spotlights the dual needs for improved biological fidelity to in vivo, along with reproducibility, especially in regulatory applications. The need for pre‐clinical models of patient‐derived endometriosis lesions motivates the development of a vascularizable, completely synthetic ...
Lauren Pruett +7 more
wiley +1 more source
Cyclic beta-hairpin-based peptide binders
The present invention provides a cyclic β-hairpin based peptide binder having a novel construct. The cyclic β-hairpin based peptide binder of the present invention can be used as a medicine, can be used for detection of in vivo materials, in vivo ...
김대진, 전상용, 전형수
core
PolyGraph, a flexible graphene‐polycaprolactone nanocomposite, unites conductivity, biocompatibility, and processability for next‐generation neural interfaces. Fabricated into microneedle arrays with ultra‐flexible backings, PolyGraph enables bidirectional neuronal recording and stimulation in brain tissue, advancing brain‐computer interface (BCI) and ...
Jack Maughan +12 more
wiley +1 more source
SICLOPPS cyclic peptide libraries in drug discovery.
A. Tavassoli
semanticscholar +1 more source
Aptamer‐Based Delivery Systems for VEGF and NGF Modulation in Ocular Therapies
Aptamer‐based delivery systems targeting NGF and VEGF hold significant potential for precise and sustained treatment of complex diseases affecting both the anterior and posterior segments of the eye. This review critically summarizes current strategies for NGF and VEGF delivery as well as VEGF sequestration, providing a clinical perspective on how ...
Nadine Best +5 more
wiley +1 more source
Structure-based design and optimization of cyclic peptide ligands targeting delta-like ligand 3. [PDF]
Gao X +5 more
europepmc +1 more source
MSF-CPMP: a novel multi-source feature fusion model for prediction of cyclic peptide membrane permeability [PDF]
Zhang Y +8 more
europepmc +2 more sources
The image shows a schematic form a nanobody‐conjugated theranostic prodrug (NBD) platform targeting tumor‐associated αvβ3 integrin. The NBD system integrates selective nanobody‐mediated tumor recognition, glutathione‐responsive disulfide cleavage for doxorubicin release, and aza‐BODIPY‐based near‐infrared fluorescence for real‐time imaging.
Sanu Karan +13 more
wiley +1 more source
Parameterizing non-canonical amino acids for cyclic peptide simulations. [PDF]
Wijesiri NK, Brown BP.
europepmc +1 more source

